Hypertensive diseases of pregnancy, mainly PET,
consist of several diseases which are associated with increased morbidity
and mortality rates both maternal and fetal wise. Its incidence among pregnant
females is about 3% -10%.This study included 500 pregnant PET women, and they
categorized to mild and severe forms, after exclusion of cases with essential
hypertension, renal disease and SLE. All pregnant ladies underwent history
taking, abdominal examination (general and local), obstetric ultrasound,
Doppler ultrasound, laboratory investigations; treatment received
(antihypertensive medications, magnesium sulphate (MgSO4) and
steroids) and finally follow up till delivery. Regarding complications, PET can
result in serious fetal/neonatal or maternal complications.By the beginning of this study we started with 380
mild cases and 120 severe cases, but the end of the study 50 cases of mild PET
were lost during follow up and 70 cases of mild PET converted into severe form.
The aim of this study is to evaluate the management protocols of preeclamptic
cases admired to Elshatby maternity hospital to minimize maternal and fetal
morbidity and mortality. RESULTS: The results showed that the incidence of PET
is significant in both young and old age, higher incidence of IUGR in sever
PET, the use of corticosteroids and MgSO4
References
[1]
Laganà, A.S., Favilli, A., Triolo, O., Granese, R. and Gerli, S. (2016) Early Serum Markers of Pre-Eclampsia: Are We Stepping Forward? The Journal of Maternal-Fetal & Neonatal Medicine, 29, 3019-3023.
https://doi.org/10.3109/14767058.2015.1113522
[2]
Wallis, A.B., Saftlas, A.F., Hsia, J. and Atrash, H.K. (2008) Secular Trends in the Rates of Preeclampsia, Eclampsia, and Gestational Hypertension, United States, 1987-2004. American Journal of Hypertension, 21, 521-526.
https://doi.org/10.1038/ajh.2008.20
[3]
Duley, L. (2009) The Global Impact of Pre-Eclampsia and Eclampsia. Seminars in Perinatology, 33, 130-137. https://doi.org/10.1053/j.semperi.2009.02.010
[4]
Porreco, R.P. and Barkey, R. (2010) Peripartum Intensive Care. The Journal of Maternal-Fetal & Neonatal Medicine, 23, 1136-1138.
https://doi.org/10.3109/14767058.2010.490890
[5]
Goldenberg, R.L., Culhane, J.F., Iams, J.D. and Romero, R. (2008) Epidemiology and Causes of Preterm Birth. Lancet, 371, 75-84.
https://doi.org/10.1016/S0140-6736(08)60074-4
[6]
Sibai, B., Dekker, G. and Kupferminc, M. (2005) Pre-Eclampsia. Lancet, 365, 785-799. https://doi.org/10.1016/S0140-6736(05)17987-2
[7]
Wagner, R., Miller, S. and O’Shaughnessy, A. (2004) Area Wide Electronic Booking: a Revolution in the Management of Health and Well Being. Studies in Health Technology and Informatics, 100, 169-173.
[8]
National High Blood Pressure Education Program (2000) Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. American Journal of Obstetrics and Gynecology, 183, S1-S22.
https://doi.org/10.1067/mob.2000.107928
[9]
American College of Obstetricians and Gynecologists (2013) Hypertension in Pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstetrics & Gynecology, 122, 1122-1131. https://doi.org/10.1097/01.aog.0000437382.03963.88
[10]
Jeyabalan, A., Powers, R.W., Durica, A.R., Harger, G.F., Roberts, J.M. and Ness, R.B. (2008) Cigarette Smoke Exposure and Angiogenic Factors in Pregnancy and Preeclampsia. American Journal of Hypertension, 21, 943-947.
https://doi.org/10.1038/ajh.2008.219
[11]
Karumanchi, S. A. and Levine, R. J. (2010) How Does Smoking Reduce the Risk of Preeclampsia? Hypertension, 55, 1100-1101.
https://doi.org/10.1161/HYPERTENSIONAHA.109.148973
[12]
Dulak, J., Deshane, J., Jozkowicz, A. and Agarwal, A. (2008) Heme Oxygenase-1 and Carbon Monoxide in Vascular Pathobiology. Circulation, 117, 231-241.
https://doi.org/10.1161/CIRCULATIONAHA.107.698316
[13]
Fisher, S.J. (2015) Why Is Placentation Abnormal in Preeclampsia? American Journal of Obstetrics and Gynecology, 213, S115-S122.
https://doi.org/10.1016/j.ajog.2015.08.042
[14]
George, E.M. and Granger, J.P. (2011) Endothelin: Key Mediator of Hypertension in Preeclampsia. American Journal of Hypertension, 24, 964-969.
https://doi.org/10.1038/ajh.2011.99
[15]
Maynard, S.E., Venkatesha, S., Thadhani, R. and Karumanchi, S.A. (2005) Soluble Fms-Like Tyrosine Kinase 1 and Endothelial Dysfunction in the Pathogenesis of Preeclampsia. Pediatric Research, 57, 1-7.
https://doi.org/10.1203/01.PDR.0000159567.85157.B7
[16]
Palei, A.C., Spradley, F.T., Warrington, J.P., George, E.M. and Granger, J.P. (2013) Pathophysiology of Hypertension in Pre-Eclampsia: A Lesson in Integrative Physiology. Acta Physiologica, 208, 224-233. https://doi.org/10.1111/apha.12106
[17]
Powe, C.E., Levine, R.J. and Karumanchi, S.A. (2011) Preeclampsia, a Disease of the Maternal Endothelium: The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease. Circulation, 123, 2856-2869.
https://doi.org/10.1161/CIRCULATIONAHA.109.853127
[18]
Venkatesha, S., Toporsian, M., Lam, C., Hanai, J., Mammoto, T., Kim, Y.M., et al. (2006) Soluble Endoglin Contributes to the Pathogenesis of Preeclampsia. Nature Medicine, 12, 642-649. https://doi.org/10.1038/nm1429
[19]
Kotz, S., Balakrishnan, N., Read, C. and Vidakovic, B. (2006) Encyclopedia of Statistical Sciences. 2nd Edition, Wiley-Interscience, Hoboken.
[20]
Kirkpatrick, L. and Feeney, B. (2013) A Simple Guide to IBM SPSS Statistics for Version 20.0. Student Edition, Wadsworth, Cengage Learning, Belmont.
[21]
Jasovic-Siveska, E. and Jasovic, V. (2015) Fetal Growth and Body Proportion during Pre-Eclamptic Pregnancy. Obstetrics & Gynecology International Journal, 2, 91-98.
https://doi.org/10.15406/ogij.2015.02.00038
[22]
Sharma, K.J., Esakoff, T.F., Guillet, A., Burwick, R.M. and Caughey, A.B. (2017) Pregnancies Complicated by Both Preeclampsia and Growth Restriction between 34 and 37 Weeks’ Gestation Are Associated with Adverse Perinatal Outcomes. The Journal of Maternal-Fetal & Neonatal Medicine, 30, 2342-2345.
https://doi.org/10.1080/14767058.2016.1248394
[23]
Weiler, J., Tong, S. and Palmer, K.R. (2011) Is Fetal Growth Restriction Associated with a More Severe Maternal Phenotype in the Setting of Early Onset Pre-Eclampsia? A Retrospective Study. PLoS ONE, 6, e26937.
https://doi.org/10.1371/journal.pone.0026937
[24]
Duley, L., Gülmezoglu, A.M. and Chou, D. (2010) Magnesium Sulphate versus Lytic Cocktail for Eclampsia. The Cochrane Database of Systematic Reviews, vol, Article No. CD002960. https://doi.org/10.1002/14651858.CD002960.pub2
[25]
Haram, K., Svendsen, E. and Abildgaard, U. (2009) The HELLP Syndrome: Clinical Issues and Management. A Review. BMC Pregnancy and Childbirth, 9, Article No. 8. https://doi.org/10.1186/1471-2393-9-8
[26]
Ramos Amorim, M.M., Katz, L. and de Almeida, S.T. (2016) 19 Accuracy of Fullpiers Score for Prediction of Morbidity/Mortality in Patients with Severe Preeclampsia in Northeastern Brazil: Medical Complications of Pregnancy Related to Hypertensive Syndromes. Pregnancy Hypertension, 6, 187.
https://doi.org/10.1016/j.preghy.2016.08.101
[27]
Aabidha, P.M., Cherian, A.G., Paul, E. and Helan, J. (2015) Maternal and Fetal Outcome in Pre-Eclampsia in a Secondary Care Hospital in South India. Journal of Family Medicine and Primary Care, 4, 257-260.
https://doi.org/10.4103/2249-4863.154669
